Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Invesco
IVZ
$13.8B
| $62.4M | 0.02% |
2,587,839
-237,941
| -8% | -$5.95M |
|
727
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $62.1M | 0.02% |
466,671
+2,355
| +0.5% | +$318K |
|
|
CTRA
728
DELISTED
Coterra Energy
CTRA
| $61.9M | 0.02% |
2,844,992
+108,845
| +4% | +$1.87M |
|
729
Las Vegas Sands
LVS
$29.6B
| $61.9M | 0.02% |
1,690,604
+106,544
| +7% | +$4.57M |
|
730
Cathay General Bancorp
CATY
$4.25B
| $61.6M | 0.02% |
1,488,325
+156,953
| +12% | +$6.12M |
|
731
SL Green Realty
SLG
$3.95B
| $61.5M | 0.02% |
868,787
+15,595
| +2% | +$1.14M |
|
|
MRTX
732
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $61.4M | 0.02% |
347,025
+4,757
| +1% | +$765K |
|
733
APA Corp
APA
$14.2B
| $61.3M | 0.02% |
2,859,437
+23,064
| +0.8% | +$441K |
|
734
First American
FAF
$7.32B
| $61.3M | 0.02% |
913,507
-17,229
| -2% | -$1.15M |
|
735
Pinnacle Financial Partners Inc
PNFP
$16B
| $61.1M | 0.02% |
649,623
+10,658
| +2% | +$980K |
|
736
Essential Utilities
WTRG
$11.4B
| $61.1M | 0.02% |
1,326,303
+55,596
| +4% | +$2.69M |
|
737
Zscaler
ZS
$28.9B
| $60.8M | 0.02% |
231,884
+13,343
| +6% | +$3.35M |
|
738
Silicon Laboratories
SLAB
$7.22B
| $60.8M | 0.02% |
433,805
-22,459
| -5% | -$3.37M |
|
739
First Solar
FSLR
$25.9B
| $60.7M | 0.02% |
636,242
+87,598
| +16% | +$8.13M |
|
740
Huntington Ingalls Industries
HII
$12.9B
| $60.7M | 0.02% |
314,486
+8,573
| +3% | +$1.73M |
|
741
Ares Management
ARES
$32.3B
| $60.7M | 0.02% |
822,161
-18,841
| -2% | -$1.36M |
|
742
Middleby
MIDD
$5.43B
| $60.6M | 0.02% |
355,464
+5,553
| +2% | +$1M |
|
743
First Financial Bankshares
FFIN
$4.99B
| $60.5M | 0.02% |
1,317,664
+228,216
| +21% | +$10.8M |
|
744
Equitable Holdings
EQH
$14B
| $60.5M | 0.02% |
2,039,958
+30,922
| +2% | +$936K |
|
745
NIO
NIO
$11.6B
| $60.5M | 0.02% |
1,696,864
+31,288
| +2% | +$1.29M |
|
|
AXON
746
Axon Enterprise
AXON
$51.7B
| $60.4M | 0.02% |
345,052
-134,350
| -28% | -$24.4M |
|
747
Newell Brands
NWL
$2.62B
| $60.4M | 0.02% |
2,726,995
+58,630
| +2% | +$1.5M |
|
|
BLD
748
DELISTED
TopBuild
BLD
| $60.2M | 0.02% |
294,076
+8,365
| +3% | +$1.76M |
|
749
Graco
GGG
$13.5B
| $60.2M | 0.02% |
860,312
+24,758
| +3% | +$1.9M |
|
|
SEE
750
DELISTED
Sealed Air
SEE
| $60.1M | 0.02% |
1,097,561
+10,018
| +0.9% | +$582K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.